Octapharma GmbH
Walther-Nernst-Str. 3, 12489 Berlin
Schwerpunkte
Octapharma’s core business is the development, production and sale of safe and effective medicines derived from human proteins in the following areas:
- Haematology (coagulation disorders)
- Immunotherapy (immune disorders)
- Intensive Care and Emergency Medicine